Introduction
Staphylococcus aureus is one of the most commonly isolated pathogens [1] , accounting for c. 46% of infections in intensive care units [2] and hospital outbreaks of methicillin-resistant S. aureus (MRSA) are a worldwide problem. Rapid differentiation of MRSA from methicillin-sensitive S. aureus (MSSA) is essential for appropriate therapy and timely intervention for cross-infection control, but conventional methods are time-consuming and costly [3] . Subtyping of MRSA in putative outbreaks increases costs and adds further delay. The emergence of epidemic MRSA (EMRSA), such as types 15 and 16 in England and Wales [4] , increases the requirement for fine discrimination in typing. Molecular subtyping methods, e.g., pulsed-field gel electrophoresis (PFGE), provide finer discrimination than the traditional phage-typing technique, but take several days to perform [5] . Although rapid methods to detect methicillin resistance based on the mecA PCR have been developed [6] , there are problems. The mecA gene occurs in some coagulasenegative staphylococci (CNS) and in some strains of S. aureus that are phenotypically methicillin sensitive [7] .
Mass spectrometry has been used widely for identification and typing of micro-organisms [8, 9] . Early work involved solvent extraction and chemical modification before analysis, but some methods use simple specimen preparation and direct analysis via appropriate ionisation methods [10] . Fast atom bombardment, electron impact and electrospray ionisation are extensively used for analysis of solvent extracts or volatile derivatives [11, 12] . Prior separation of components of mixtures by chromatographic procedures, sometimes on-line by direct coupling to the mass spectrometer, has also been employed [13] . Until recently [14] , whole-cell analysis has centred on pyrolysis mass spectrometery [15] . All these approaches have drawbacks: complicated sample preparation or extraction procedures, Matrix-assisted laser desorption ionisation time-offlight mass spectrometry (MALDI-TOF-MS) is an established technique for profiling bacterial proteins from cell extracts [16] . Recently, this technique has been applied to intact bacterial cells technique termed intact cell mass spectrometry (ICMS), providing a reproducible spectrum within minutes [14, 17] . Bacterial cells are applied to a sample slide, matrix is added and the slide is transferred to the mass spectrometer.
Here, a laser beam vaporises the matrix, which carries away and ionises large mol. wt. (500-10 000) fragments from the cell surface into the vapour phase. These ions are extracted into a drift tube, where they separate and are sequentially delivered to a detector in order of their mass:charge (m:z) ratio. Negative and positive ions are produced and either can be analysed. This report summarises preliminary experiments in which ICMS was applied to discrimination between MRSA and MSSA. Samples were analysed with a Kompact MALDI 2 linear, time-of-flight mass spectrometer (Kratos Analytical), desorbing with a 3-ns pulse of nitrogen laser light (337 nm wavelength) of intensity just above the threshold for ion production. Positive ions were extracted with an accelerating voltage of þ20 kV [13] . Spectra for individual specimens were compiled, averaging results from 100 shots taken across the width of the specimen for m:z values 500-10 000. Spectra for the 10 replicates were compared to determine withinisolate peak reproducibility, then summed to minimise random effects of baseline drift and noise. Only peaks with intensities .0.4 mV after baseline subtraction were considered in the analysis. The presence and absence of peaks were considered as fingerprints for the particular isolate. Results were transferred to Excel spreadsheets and subjected to hierarchical cluster analysis by using the Dice similarity coefficient in the statistical suite SPSS for Windows.
Materials and methods

Results and discussion
Within-strain reproducibilty was good; peaks were resolved with AE0.1% reproducibility (manufacturer's specification) on the mass:charge (m:z) scale. Over 90% of the peaks were reproduced in all replicates and relative intensities (but not absolute intensities) were closely comparable. Other studies (unpublished data) have shown little loss in reproducibility between batches analysed on different days. Most peaks were found in the m:z range 500-2000. Typical replicate spectra for MSSA (NCIMB 8625) are shown in Fig. 1 .
Peak conservation is illustrated in Table 1 . Some peaks (at m:z 525, 617, 734, 760, 787, 798 and 826) were present in all isolates, some were invariably present in, and unique to, MRSA (e.g., 891, 1140, 1165, 1229 and 2127) or MSSA (e.g., 2548 and 2647) and many were unique to individual strains. MSSA strains produced small numbers of peaks (37-67) and MRSA strains produced more (82-209), allowing ready visual discrimination. The spectra of the CNS showed marked inter-species differences, but could be divided into two broad groups, one with few peaks (30-48) comprising S. epidermidis and S. warneri, and the other with 92-106 peaks, comprising S. haemolyticus, S. saprophyticus and S. cohnii. Spectra were readily discriminated on visual inspection into the tight distinct MRSA and MSSA groups and a widely varied, but distinct miscellany of CNS strains.
At a finer level of discrimination, there were visually obvious differences between almost all the MRSA isolates, particularly in the peak patterns within m:z ranges 1100-1250, 1290-2040 and 3060-3220. However, two pairs of MRSA isolates were not readily distinguished in ICMS either visually or in mathematical analysis (Dice coefficient .70% similarity). These pairs were also indistinguishable by phage and PFGE typing: one pair were both EMRSA 15 PFGE type 5 and the other were both EMRSA 16 PFGE type 1. These were the only pairs among the MRSA isolates that were indistinguishable by conventional typing.
The clarity of discrimination between MSSA and MRSA strain spectra (Fig. 2 ) and the speed of the method suggest a potential role for ICMS in the diagnostic laboratory. Up to 10 isolates, with 10 replicates of each, could be analysed and categorised per hour. Conventional approaches that distinguish between MRSA and MSSA are slow. This introduces delays in guided treatment decisions and leaves little opportunity for the early intervention that is essential to limit the spread of MRSA. ICMS offers an opportunity to minimise the delay, and so reduce the financial and human costs of MRSA nosocomial infections. There is the additional benefit that ICMS has potential as a finely discriminatory typing tool, which is clearly pertinent to this application. From these preliminary results, ICMS spectra appear to contain data that are relevant at three levels: species identification, typing at a gross level into MRSA or MSSA, and typing at the fine level attained in PFGE. If this is so, then there are many further applications for ICMS in medical microbiology. However, there is a clear need for larger scale trials to be undertaken before these claims can be confirmed.
